Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma

Journal of Human Genetics

Volumn 43, Issue 2, 1998, Pages 101-106

  Shirahama, Syuya ^a   Ogura, Kenji ^a   Takami, Hiroshi ^b   Ito, Kunihiko ^c   Tohsen, Tohichi ^d   Miyauchi, Akira ^e   Nakamura, Yusuke ^f  

^a SRL INC   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c ITO HOSPITAL   (Japan)

^d Tohsen Clinic   (Japan)

^e KAGAWA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Familial medullary thyroid carcinoma (FMTC); Multiple endocrine neoplasia type 2 (MEN2); RET proto oncogene; Sporadic medullary thyroid carcinoma (MTC)

Indexed keywords

DNA; DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA;

ARTICLE; ASIAN; CODON; EXON; GENETICS; HUMAN; JAPAN; MEDULLARY CARCINOMA; MUTATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SIPPLE SYNDROME; THYROID TUMOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, MEDULLARY; CODON; DNA; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; EXONS; GERM-LINE MUTATION; HUMANS; JAPAN; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0031626942     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380050048     Document Type: Article

References (17)

1. Blaugrund JE, Johns MM Jr, Eby YJ, Ball DW, Balylin SB, Hruban RH, Sidransky D (1994) RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet 3: 1895-1897
2. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA Jr, Goodfellow PJ, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91: 1579-1583
3. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmor TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2: 851-856
4. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V (1996) GDNF signalling through the RET receptor tyrosine kinase. Nature 381: 789-793
5. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gondner E, Scheumann GFW, Jackson CE, Tunnacliffe A, Ponder BAJ (1994) Point mutations within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 3: 237-241
6. Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD, Ponder BAJ (1995a) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and a family with FMTC. Oncogene 10: 509-513
7. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HPH, Pfragner R, Behmel A, Lorenzo MJ, Stonehouse TL, Ponder MA, Ponder BAJ (1995b) Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosome Cancer 12: 209-212
8. Farnden JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS, Wells SA Jr (1986) Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 73: 278-281
9. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppeer JWM, Amstel HKP, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375-376
10. Mathew CGP, Chin KS, Watson DF, Thorpe K, Canter C, Liou GL, Fong SL, Bridges CDB, Haak H, Nieuwenhuijzen-Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BAJ (1987) A linked genetic marker for multiple endocrine neoplasia type 2a on chromosome 10. Nature 328: 527-528
11. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Tribodeau SN, Ponder BAJ (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6: 70-74
12. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and polymorphisms using the polymerase chain reaction. Genomics 5: 874-879
13. Schimke RN (1984) Genetic aspects of multiple endocrine neoplasia. Annu Rev Med 35: 25-31
14. Schuffenecker I, Ginet N, Goldger D, Eng C, Chambe B, Boneu A, Houdent C, Pallo D, Schlumberger M, Thivolet C, Lenoir GM and Le Groupe d'Etude des Tumeurs a Calcitonine (1997) Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Am J Hum Genet 60: 233-237
15. Shirahama TS, Koyama K, Miyauti A, Wakasugi T, Oishi S, Takami H, Hikiji K, Nakamura Y (1995) Germline mutations of the RET protooncogene in Japanese patients with multiple endocrine neoplasia type 2A (MEN2A) Hum Genet 95: 187-190
16. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AMV, Farrer LA, Brasch K, Castiglione C, Genel M, Gertner J, Greenberg CR, Gusella JF, Holden JJA, White BN (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328: 528-530
17. Trupp M, Ernest A, Michael F, Nilsson A-S, Sieber B-A, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sariola H, Saarma M, Ibanez CF (1996) Functional receptor for GDNF encoded by the c-RET proto-oncogene. Nature 381: 785-789